Frazier Life Sciences Public Fund, L.P. is 10% Owner at Viridian Therapeutics, Inc.\DE (VRDN). They have made 1 open-market trade across 1 company since 2021, most recently 2021-09-23.
CIK 0001863769
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.2M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRDN | 1,505,200 | $28.7M |
Shares reported on the most recent Form 4, priced at the 2021-09-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRDN | BUY | 2021-09-23 | 2021-09-28 | $11.00 | $2.2M | -8.9% | +2.2% | +18.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.